Compliance Investigations & White Collar


Ullman Quoted on Labeling Calories in Sports Nutrition Products
July 7, 2021 | Compliance Investigations & White Collar
Marc Ullman was quoted in the NutraIngredients-USA.com article, “Experts offer clarity on labeling calories for non-macronutrients.” The article focuses on the citizen’s petition filed by the Natural Products Association regarding the labeling of calories from branched chain amino acids. Ullman explained that there are some issues with the regulation. “There’s no way to put these …
Read More
Ullman Quoted on FTC’s “Made in the USA” Rule
July 6, 2021 | Compliance Investigations & White Collar
Marc Ullman commented in the NutraIngredients-USA.com article, “FTC finalizes ‘Made in the USA’ rule.” According to the article, the Federal Trade Commission has issued its final ‘Made in the USA’ rule about how companies can make this claim on their packaging and in advertising. In regards to dietary supplements, “Made in the USA claims continue …
Read More
Ullman Comments on FDA’s Handling of New Dietary Ingredients
July 1, 2021 | Compliance Investigations & White Collar
Marc Ullman was quoted in the NutraIngredients-USA article, “FDA lists NDI update among priorities for coming year.” The article discusses a list of priorities released yesterday by the US Food and Drug Administration (FDA), which included New Dietary Ingredients (NDI) Draft Guidance. “FDA’s entire handling of NDIs has been absurd,” Ullman said. “It seems to …
Read More
Kutner Discusses NPDB Reporting with Hospital Peer Review
June 30, 2021 | Compliance Investigations & White Collar | Health Services
Christopher J. Kutner was quoted extensively in the Hospital Peer Review article, “NPDB Reporting Protected by Law in Some Cases, Gray Areas Problematic.” The article discusses the protections afforded to hospitals that report doctors to the National Practitioner Data Bank (NPDB). The story also details the situations in which the protection may not be ironclad, …
Read More
Flynn Honored at Outstanding Women in Law Awards by Hofstra University
June 22, 2021 | Compliance Investigations & White Collar | Insurance Fraud
Kaitlyn Flynn is an honoree at the Outstanding Women in Law Awards and Garden Party hosted by Hofstra University. The June 23, 2021 event featured a virtual conversation with Lifetime Achievement Honoree and Special Guest Speaker Secretary Hillary Rodham Clinton. …
Read More
Rivkin Radler Lunch-and-Learn Series: The Impact of Stark Law and AKS Changes on Compliance in Real Estate Transactions
June 21, 2021 | Real Estate, Zoning & Land Use | Compliance Investigations & White Collar | Health Services
Please join us as Rivkin Radler attorneys Benjamin P. Malerba and Ada Janocinska discuss key compliance considerations under the federal Anti-Kickback Statute (AKS) and Stark Law as they relate to real estate transactions. The presentation will provide: • An overview of the changes in the laws • Practical examples of when these laws would apply …
Read More
Ullman Comments on FDA’s Failure to Regulate the CBD Market
June 16, 2021 | Compliance Investigations & White Collar
Marc Ullman was quoted in the NutraIngredients-USA article, “COVID-19 and legal chaos dent CBD market – but Congress and a stronger economy offer hope.” The article discusses the state of the CBD market amid the COVID-19 pandemic and legal battles. Ullman says the market is in disarray due to the FDA’s inaction. Read the full …
Read More
Rivkin Radler Lunch-and-Learn Series: How to avoid False Claims Act violations
May 21, 2021 | Compliance Investigations & White Collar | Health Services
Please join us on June 10 from 12 to 1 p.m. as Rivkin Radler Partner Robert H. Iseman discusses False Claims Act (FCA) compliance. The FCA applies to any person or entity doing business with the federal government. Every year the federal government collects billions of dollars from FCA defendants, and most of that is …
Read More
Ullman Comments About Risk to NAC Retailers
May 17, 2021 | Compliance Investigations & White Collar
Marc Ullman was quoted in the Natural Products Insider article, “Stakeholders can’t sue FDA over NAC warning letters.” A recent court decision prevents stakeholders from suing the FDA based merely on its positions asserted in warning letters. The article discusses how a lingering dispute between the agency and the dietary supplement industry regarding NAC (N-acetyl-L-cysteine) …
Read More
A Conversation with the New Acting Medicaid Inspector General
April 28, 2021 | Compliance Investigations & White Collar | Health Services
On Thursday, May 13 from 12 to 1 p.m, Frank T. Walsh, Jr., the new Acting Medicaid IG, will provide an overview of OMIG’s priorities and key initiatives. He will also address participants’ questions, which are to be submitted at registration. The program will be moderated by Robert Hussar, a partner in Rivkin Radler’s Compliance, …
Read More
Next Page

Get legal updates and news delivered to your inbox